Press release
Monkeypox Treatment Market: Industry Trends, Analysis, Types, Growth, Opportunity and Forecast 2022-2033
Download Free Exclusive Sample PDF@https://www.emergenresearch.com/request-sample/3547
Key Growth Factors
The rise in monkeypox cases is fueling demand for antiviral drugs, immunoglobulins, and vaccines repurposed from smallpox treatments. Pharmaceutical companies are actively investing in research to develop targeted therapies and diagnostic tools. Public health initiatives, including vaccination drives and awareness campaigns, are also contributing to market growth.
Government funding and partnerships between healthcare organizations are playing a critical role in the development and distribution of treatment solutions. In July 2022, the U.S. Department of Health and Human Services (HHS) made 144,000 doses of the JYNNEOS vaccine available to curb the spread of monkeypox. Similarly, in September 2024, the World Health Organization (WHO) prequalified the MVA-BN vaccine as the first approved vaccine for monkeypox prevention.
Market Challenges
One of the major challenges facing the monkeypox treatment market is the high cost of production. The development of vaccines and antiviral treatments requires advanced biotechnology infrastructure, extensive clinical trials, and regulatory approvals, leading to increased production costs. Limited patient numbers also contribute to higher per-unit expenses, impacting affordability and access, particularly in low-income regions. Additionally, specialized vaccine storage and distribution requirements, such as cold chain logistics, further add to the financial burden.
Interested in knowing more relevant information? Click here:https://www.emergenresearch.com/industry-report/monkeypox-treatment-market
Market Segmentation
The monkeypox treatment market is segmented by dosage form into oral and injectable treatments. Oral formulations hold the largest market share due to their convenience, ease of administration, and growing adoption in stockpiling programs. Government initiatives and advancements in antiviral drug development are further driving demand for oral treatments.
Injectables, on the other hand, are the fastest-growing segment. The increasing frequency of outbreaks, accelerated regulatory approvals, and growing investments in vaccine research contribute to this trend. Smallpox-based injectables are gaining attention as part of broader monkeypox management strategies.
Monkeypox Treatment Top Companies and Competitive Landscape
The prominent companies in the monkeypox treatment market are SIGA Technologies Inc., Chimerix, Inc., Sanofi SA, and Bavarian Nordic. These businesses are making substantial investments in architectural paint research and development. Promising growth methods like collaborative partnerships, mergers and acquisitions, product launches, and and others are increasingly being employed by companies dealing in monkeypox treatment to propel their growth.
In September 2022, the U.S. FDA announced further steps to boost monkeypox testing capacity and accessibility in response to the current outbreak. Under this initiative, the FDA is expected to recommend EUA requests for monkeypox diagnostic tests and promote diagnosis.
Some of the key companies in the global Monkeypox Treatment market include:
SIGA Technologies Inc.
Chimerix, Inc.
Bavarian Nordic
Sanofi SA
Emcure Pharmaceuticals
Jinan Jinda Pharmaceutical Chemistry Co., Ltd
Emergent Pharmaceuticals
Gilead Sciences, Inc.
Hetero
Piramal Pharma Solutions
Monkeypox Treatment Latest Industry Updates
In June 2022, Cepheid and BioGX collaborated to provide a PCR test for monkeypox that will run on the GeneXpert system. The GeneXpert system has a global installed base of around 40,000 in 180 countries.
In June 2022, CerTest Biotec and Becton, Dickinson, and Company created a molecular diagnostic test designed to detect the Monkeypox virus.
Make Payment [Buy your Exclusive copy] @https://www.emergenresearch.com/select-license/3547
The main report offers detailed historical data and forecasts revenue growth at a global, regional, and country level, and provides analysis of the market trends in each of the segments from 2020 to 2033:
Monkeypox Treatment Market Segmentation Analysis
Treatment Type Outlook (Revenue, USD Million; 2020-2033)
Prophylactic- Vaccines
Therapeutic
Tecovirimat
Brincidofovir
Cidofovir
Dosage Outlook (Revenue, USD Million; 2020-2033)
Oral
Injectable
Distribution Channel Outlook (Revenue, USD Million; 2020-2033)
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Regional Outlook (Revenue, USD Million; 2020-2033)
North America
United States
Canada
Mexico
Europe
Germany
France
United Kingdom
Italy
Spain
Benelux
Rest of Europe
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Rest of Latin America
Middle East and Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of MEA
Request Customization in The Report @ https://www.emergenresearch.com/request-for-customization/3547
Look Over transcripts provided by Emergen Research
Monkeypox Treatment Market Size @https://www.emergenresearch.com/industry-report/monkeypox-treatment-market/market-size
Monkeypox Treatment Market Share @https://www.emergenresearch.com/industry-report/monkeypox-treatment-market/market-share
Monkeypox Treatment Market Trends @https://www.emergenresearch.com/industry-report/monkeypox-treatment-market/market-trends
Monkeypox Treatment Regional Market Demand @https://www.emergenresearch.com/industry-report/monkeypox-treatment-market/regional-market-demand
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Monkeypox Treatment Market: Industry Trends, Analysis, Types, Growth, Opportunity and Forecast 2022-2033 here
News-ID: 3845842 • Views: …
More Releases from Emergen Research
Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion …
The global Internet of Things (IoT) in Healthcare Market was valued at USD 299.05 billion in 2023 and is expected to grow at a CAGR of 16.5% during the forecast period. This growth is fueled by the rising use of connected healthcare devices, increasing demand for early disease detection through remote monitoring, and growing adoption of artificial intelligence (AI) tools within IoT-based healthcare systems.
The market is also benefiting from the…
Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13 …
The global Stem Cell Therapy Market, valued at USD 13.7 billion in 2024, is projected to reach USD 49.2 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.6%. Growth is being fueled by the rising burden of chronic diseases, rapid progress in cell-based studies, and increasing investments in regenerative medicine and personalized healthcare solutions.
Stem cell therapies offer the ability to repair, replace, or restore damaged tissues…
Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophistic …
The global Artificial Intelligence in cybersecurity market size was USD 23.8 Billion in 2023 and is expected to reach a market valuation of USD 29.44 billion by the end of 2024 registering a CAGR of 23.7% during the forecast period. The adoption of Artificial Intelligence (AI) in cybersecurity is rapidly gaining traction as organizations worldwide face increasingly complex and frequent cyber threats. By combining advanced technologies such as Machine Learning…
Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing …
The global regenerative medicine market, valued at USD 34.2 billion in 2024, is set to grow to USD 125.6 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.9%. Growth is being fueled by rising approvals of advanced therapies, strong demand for personalized treatments in cancer and orthopedics, and expanding cell and gene therapy manufacturing across major markets such as North America, Europe, and Asia.
Once seen as…
More Releases for Monkeypox
Monkeypox Market Size, Share, and Growth Opportunities 2029
This Monkeypox Market report has been prepared by considering several fragments of the present and upcoming market scenario. The market insights gained through this market research analysis report facilitates more clear understanding of the market landscape, issues that may interrupt in the future, and ways to position definite brand excellently. It consists of most-detailed market segmentation, thorough analysis of major market players, trends in consumer and supply chain…
Monkeypox Treatment Market Is Estimated To Witness High Growth Owing To Increase …
Market Overview:
Monkeypox is an orthopoxvirus that causes rash and skin lesions in humans. The current outbreak has highlighted the need for effective treatments to address monkeypox symptoms and complications.
Market Dynamics:
The Monkeypox Treatment Market is anticipated to witness significant growth over the forecast period, driven by increased monkeypox cases globally. According to the World Health Organization (WHO), as of October 2022, there have been over 77,000 confirmed monkeypox cases across 110…
Global Monkeypox Testing Market Size
According to a new market research report published by Global Market Estimates, the Global Monkeypox Testing Market is expected to grow at a CAGR of 4.5% from 2023 to 2028.
The demand for effective diagnostics in the monkeypox testing market is driven by increasing outbreaks and public health emergencies. Growing awareness among governments and healthcare organizations regarding monitoring and containment boosts market growth. Advanced test kits enable accurate detection and differentiation,…
Monkeypox Testing Market - Unmasking Monkeypox: Accurate Diagnostic Solutions
Newark, New Castle, USA - new report, titled Monkeypox Testing Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Monkeypox Testing market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Monkeypox Testing market. The report offers an overview of the market, which…
Monkeypox Market Research: Market Segmentation and Competitive Analysis
When any business seek to lead the market or make a mark in the market as a fresh emergent, market research report is always central. A comprehensive Monkeypox Market report encompasses a market data that provides a detailed analysis of the ABC industry and its impact based on applications and different geographical regions. The report gives current as well as upcoming technical and financial details of the industry to 2027.…
Europe to Spend USD 18 Million in Monkeypox Testing by the End of 2023; More tha …
According to Arizton's latest research report, the Europe monkeypox testing market to spend USD 18 million by the end of 2023. Growing development of rapid testing methods, advancements in PCR technology, and increasing collaborations among the vendors are the growing trends in the market.
There are only a few MPX test kits available in the market. However, governments make efforts to control the virus due to its rapid spread across…
